Morning infusions may boost immunotherapy survival benefit, major analysis finds
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
A new meta-analysis of nearly 12,000 patients links early-day immune checkpoint inhibitor infusions with markedly better survival in advanced solid ...
An editorial from Clinical Cancer Bulletin maps the converging technologies — TCR-T cells, cancer organoids, multi-specific antibody-drug conjugates, nanotechnology, and ...
A major Lancet Regional Health – Europe review charts how combination immunotherapy transformed advanced hepatocellular carcinoma treatment while exposing stark ...
Brazilian researchers engineered natural killer cells with a TCR-like CAR that recognizes an intracellular melanoma antigen displayed on HLA molecules, ...
A new analysis shows that post-progression censoring may have generated a misleading survival advantage for nivolumab in second-line mesothelioma, resolving ...
A major Lancet Regional Health – Europe analysis shows that metabolic liver disease and alcohol are driving a rising tide ...
A systematic review of 206 patients finds that bilateral claustrum hyperintensity on MRI marks a distinct, fever-triggered subset of new-onset ...
Researchers have developed fourth-generation CAR T cells targeting mucin 1 that show superior proliferation, reduced exhaustion, and enhanced tumor-killing activity ...
New research links LINE-1 retrotransposon overexpression and homologous recombination deficiency in gastric cancer to heightened immune pathway activation and potential ...
Spatial transcriptomic mapping of liver tumors has revealed that CCL19-producing fibroblasts recruit CXCR3-positive B cells to form an antitumor axis ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine